Luscher TFAngiotensin, ACE inhibitors and endothelial control of vasomotor tone . Basic Res Cardiol1993; 88 (Suppl 1): 15-24.
2.
Moreau P., d'Uscio LV, Shaw S. et al.Angiotensin II increases tissue endothelin and induces vascular hypertrophy. Circulation1997; 96:1593-7.
3.
Liu J.-L, Murakami H., Zucker IHAngiotensin II-nitric oxide interaction on sympathetic outflow in conscious rabbits. Circ Res1998; 82:496-502.
4.
Pfeffer MA, Braunwald E., Moye LA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med1992; 327:669-77.
5.
The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet1993; 342: 821-8.
6.
Kober L., Torp-Pedersen C., Carlsen JE et al. A clinical trial of the angiotensin-converting-inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction . N Engl J Med1995; 333:1670-6.
7.
McAlpine HM, Morton JJ, Leckie B. et al. Neuroendocrine activation after acute myocardial infarction . Br Heart J1988; 60: 117-24.
8.
Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarcto Miocardico.GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet1994; 343: 1115-22.
9.
ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.ISIS-4:A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet1995; 345: 669-85.
10.
Ambrosioni E., Borghi C., Magnani B. for the Survival of Myocardial Infarction Long-term Evaluation (SMILE) Study Investigators.The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction . N Engl J Med1995; 332: 80-5.
11.
Lisheng L., Wen W., Shouqi T.Chinese Cardiac Study-I (CCSI): Effects of captopril on the early mortality and complications in 14 962 patients with acute myocardial infarction . A multi-center, large-scale, randomized, double-blind, placebo-controlled clinical trial. Chin J Cardiol1997; 25: 245-51.
12.
Gaudron P., Eilles C., Ertl G., Kochsiek K.Compensatory and noncompensatory left ventricular dilatation after myocardial infarction: time course and hemodynamic consequences at rest and during exercise . Am Heart J1992; 123: 377-85.
13.
Pfeffer MA, Braunwald E.Ventricular remodelling after myocardial infarction. Experimental observations and clinical implications. Circulation1990 ; 81: 1161-72.
14.
Weber KT, Brilla CG, Cleland JGF et al. Cardioreparation and the concept of modulating cardiovascular structure and function. Blood Press1993; 2: 6-21.
15.
Kramer CM, Rogers WJ, Park CS et al. Regional myocyte hypertrophy parallels regional myocardial dysfunction during post-infarct remodelling.JMol Cell Cardiol1998; 30: 1773-8.
16.
Vaughan D., Lamas G., Pfeffer MA et al. Role of left ventricular dysfunction in selective neurohumoral activation in the recovery phase of anterior wall acute myocardial infarction . Am J Cardiol1990; 66: 529-32.
17.
Rouleau JL, de Champlain J., Klein M. et al. Activation of neurohumoral systems in postinfarction left ventricular dysfunction. J Am Coll Cardiol1993; 22: 390-8.
18.
Pfeffer MA, Pfeffer JM, Steinberg C., Finn P.Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation1985; 72: 406-12.
19.
Sharpe N., Smith H., Murphy J. et al. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet1988; 1: 255-9.
20.
Pfeffer MA, Lamas GA,Vaughan DE et al. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med1988; 319: 80-6.
21.
Moye LA, Pfeffer MA, Braunwald E.Rationale, design and baseline characteristics of the Survival and Ventricular Enlargement Trial. Am J Cardiol1991; 68: 70D-79D.
22.
Pfeffer M.The SAVE study: an overview. Br J Cardiol1994; 1 (Suppl 1): S18-20.
23.
Hall AS, Winter C., Bogle SM et al. The Acute Infarction Ramipril Efficacy (AIRE) Study: rationale, design, organization, and outcome definitions. J Cardiovasc Pharmacol1991; 18 (Suppl 2): S105-9.
24.
The TRACE Study Group.The Trandolapril Cardiac Evaluation (TRACE) study: rationale, design and baseline characteristics of the screened population. Am J Cardiol1994; 73: 44C-50C.
25.
Swedberg K. , Held P., Kjekshus J. et al. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandanavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med1992 ; 327:678-84.
26.
GISSI-3 Study Protocol on the effects of lisinopril, of nitrates, and of their association in patients with acute myocardial infarction. Am J Cardiol1992; 70: 62C-69C.
27.
ISIS-4 Collaborative Group.Fourth International Study of Infarct Survival: protocol for a large simple study of the effects of oral mononitrate, of oral captopril, and of intravenous magnesium. Am J Cardiol1991; 68: 87D-100D.
28.
Ambrosioni E., Borghi C., Magani B.Survival of Myocardial Infarction Long-term Evaluation (SMILE) Study: rationale, design, organization, and outcome definitions . Controlled Clin Trials1994; 15: 201-10.
29.
The SOLVD Investigators.Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med1992; 327: 685-91.
30.
Nicod P., Gilpin E., Dittrich H. et al. Influence on prognosis and morbidity of left ventricular ejection fraction with and without signs of left ventricular failure after acute myocardial infarction. Am J Cardiol1988; 61: 1165-71.
31.
Chinese Cardiac StudyCollaborative Group.Oral captopril versus placebo among 13634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1). Lancet1995; 345: 686-7.
32.
ACE Inhibitor MyocardialInfarction Collaborative Group.Indications for ACE inhibitors in the early treatment of acute myocardial infarction. Systematic overview of individual data from 100 000 patients in randomized trials. Circulation1998; 97: 2202-12.
33.
Cushman DW, Wang FL, Fung WC et al. Differentiation of angiotensin converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs .AmJHypertens1989; 2: 294-306.